Invitation to presentation of Q-linea’s Year-end report 2021 on February 17, 2022

Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company’s Year-end report for the period January – December 2021 on Thursday February 17, 2022 at 07:30 a.m. (CET).

Q-linea invites to an audiocast with teleconference (in English) for investors, analysts and media on February 17, 2022, at 13:00 – 14:00 p.m CET.

Jonas Jarvius, CEO, and Anders Lundin, CFO, to present Q-linea and comment on the interim report followed by a Q&A-session.

To participate, please call any of the following phone numbers from:
SE: +46 8 5055 8357
UK: +44 333 300 9261
US: +1 646 722 4903

Webcast: https://tv.streamfabriken.com/q-linea-q4-2021

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company’s lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.

Invitation to presentation of Q-linea’s Year-end report 2021 on February 17, 2022